ZVRA - Zevra Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$25.50
DETAILS
HIGH:
$26.00
LOW:
$25.00
MEDIAN:
$25.50
CONSENSUS:
$25.50
UPSIDE:
154.24%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||
| Revenue | 106.5 | 23.6 | 27.5 | 10.2 | 28.6 | 13.3 | 12.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 16.5 | 7.4 | 2.9 | 0.2 | 2.1 | 1.3 | 2.9 | 0.3 | 0.3 | 0.2 | 0.1 | 0 | 0 | 0 |
| Gross Profit | 90.0 | 16.2 | 24.5 | 9.9 | 26.6 | 12.0 | 9.9 | (0.3) | (0.3) | (0.2) | (0.1) | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||
| R&D Expenses | 12.7 | 42.1 | 39.8 | 19.8 | 10.2 | 8.8 | 19.4 | 41.8 | 20.6 | 20.5 | 13.9 | 11.9 | 3.4 | 3.0 |
| SG&A Expenses | 77.6 | 54.9 | 35.1 | 15.0 | 8.7 | 7.9 | 10.8 | 12.5 | 12.8 | 14 | 8.9 | 4.5 | 1.4 | 2.3 |
| Other Expenses | 3.9 | 6.2 | (0.8) | 17.7 | 0 | 0.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 94.2 | 103.2 | 74.1 | 52.5 | 18.9 | 17.6 | 30.2 | 54.3 | 33.4 | 34.5 | 22.8 | 16.4 | 4.7 | 0.1 |
| Operating Income | ||||||||||||||
| Operating Income | (4.2) | (87.0) | (49.6) | (42.6) | 7.7 | (5.6) | (20.3) | (55.9) | (33.4) | (37.5) | (22.8) | (16.4) | (4.7) | (5.3) |
| Interest Expense | 8.0 | 7.4 | 1.5 | 0.3 | 0.4 | 7.1 | 6.5 | 7.1 | 7.3 | 7.1 | 2.7 | 2.7 | 0.2 | 0 |
| Interest Income | 6.9 | 2.2 | 4.5 | 1.5 | 0.3 | 0.1 | 0.3 | 0.4 | 0.4 | 0.4 | 0.0 | 0.0 | 0.1 | 0.0 |
| Profitability | ||||||||||||||
| EBITDA | 98.7 | (76.4) | (43.5) | (25.5) | (7.9) | (5.4) | (17.7) | (53.9) | (33.0) | (34.3) | (22.7) | (16.4) | (4.7) | 0.4 |
| EBIT | 94.7 | (82.8) | (44.5) | (26.5) | (8.1) | (5.7) | (18.0) | (54.3) | (33.4) | (34.5) | (22.8) | (21.8) | (4.7) | (0.1) |
| Income Before Tax | 86.7 | (90.1) | (46.0) | (26.8) | (8.5) | (12.8) | (24.5) | (56.6) | (43.4) | (16.5) | (54.6) | (24.5) | (5.2) | (0.1) |
| Income Tax Expense | 3.4 | 15.4 | 0 | (0.0) | 0.0 | (0.0) | (0.0) | (0.1) | (0.0) | (0.0) | 0.0 | (0.0) | (0.0) | (0.0) |
| Net Income | 83.2 | (105.5) | (46.0) | (26.8) | (8.6) | (12.8) | (24.5) | (56.5) | (43.4) | (16.5) | (54.7) | (24.5) | (5.2) | (0.1) |
| Per Share Data | ||||||||||||||
| EPS (Basic) | 1.40 | -2.28 | -1.30 | -0.78 | -2.11 | -3.21 | -13.23 | -50.39 | -47.37 | -18.10 | -118.69 | -31.79 | -10.69 | -0.47 |
| EPS (Diluted) | 1.35 | -2.28 | -1.30 | -0.78 | -2.11 | -3.21 | -13.23 | -50.39 | -47.37 | -18.10 | -118.69 | -31.79 | -10.69 | -0.47 |
| Shares Outstanding | 55.3 | 46.3 | 35.5 | 34.5 | 29.8 | 4.0 | 1.9 | 1.1 | 0.9 | 0.9 | 0.5 | 0.8 | 0.5 | 0.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 62.4 | 33.8 | 43.0 | 65.5 | 112.3 | 4.2 | 3.2 | 18.4 | 10.9 | 16.8 |
| Short-Term Investments | 128.6 | 35.7 | 24.7 | 17.4 | 0 | 0 | 0 | 3.3 | 31.4 | 51.0 |
| Net Receivables | 23.3 | 10.5 | 17.4 | 8.3 | 1.5 | 2.6 | 1.9 | 0.1 | 2.1 | 5.1 |
| Inventory | 1.7 | 2.0 | 24.1 | 0 | 0 | 0 | 0 | 0 | 0 | 1.1 |
| Other Current Assets | 7.0 | 3.0 | (23.4) | 1.1 | 0.3 | 0.3 | 1.4 | 0 | 1.4 | 0.1 |
| Total Current Assets | 223.0 | 86.0 | 86.9 | 92.8 | 115.1 | 8.4 | 7.0 | 23.7 | 45.9 | 74.4 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 1.7 | 1.0 | 1.5 | 1.8 | 2.0 | 2.4 | 3.0 | 1.8 | 2.0 | 2.0 |
| Goodwill | 4.7 | 4.7 | 4.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 6.4 | 69.0 | 69.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 47.9 | 6.0 | 0 | 20 | 15.4 | 0 | 0 | 0 | 3.2 | 8.2 |
| Other Non-Current Assets | 1.0 | 11.4 | 9.9 | 0.7 | 0.4 | 0.4 | 0.5 | 1.3 | 1.3 | 0.4 |
| Total Non-Current Assets | 61.7 | 92.1 | 85.4 | 22.5 | 17.9 | 2.8 | 3.5 | 3.0 | 6.6 | 10.5 |
| Total Assets | 284.7 | 178.1 | 172.3 | 115.3 | 132.9 | 11.2 | 10.5 | 26.7 | 52.5 | 84.9 |
| Current Liabilities | ||||||||||
| Account Payables | 2.5 | 13.1 | 14.0 | 3.6 | 0.5 | 1.2 | 1.1 | 3.7 | 2.2 | 0.5 |
| Short-Term Debt | 0 | 0 | 37.7 | 4.7 | 0 | 0.4 | 0 | 3.3 | 3.3 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.6 | 5.7 | 0 |
| Other Current Liabilities | 22.7 | 3.2 | 10.8 | 0.7 | 0.8 | 0 | 0.2 | (4.5) | (5.6) | 0.0 |
| Total Current Liabilities | 39.3 | 34.1 | 73.7 | 12.0 | 4.2 | 7.5 | 5.4 | 12.0 | 11.5 | 6.6 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 61.9 | 59.5 | 5.1 | 12.8 | 0 | 68.0 | 77.3 | 78.1 | 89.4 | 91.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 28.0 | 44.5 | 31.2 | 14.6 | 0.4 | 0.4 | 0.3 | 2.8 | 8.5 | 5.1 |
| Total Non-Current Liabilities | 90.8 | 104.4 | 36.7 | 28.2 | 1.6 | 70.1 | 79.5 | 81.3 | 98.5 | 96.9 |
| Total Liabilities | 130.1 | 138.5 | 110.5 | 40.2 | 5.8 | 77.6 | 85.0 | 93.3 | 110.0 | 103.6 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (422.1) | (505.3) | (399.8) | (353.7) | (267.0) | (258.5) | (245.7) | (221.2) | (164.7) | (121.3) |
| Accumulated Other Comprehensive Income | (0.8) | 0.6 | (0.0) | 0.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 154.7 | 39.7 | 61.9 | 75.1 | 127.1 | (66.4) | (74.5) | (66.6) | (57.5) | (18.7) |
| Total Liabilities & Equity | 284.7 | 178.1 | 172.3 | 115.3 | 132.9 | 11.2 | 10.5 | 26.7 | 52.5 | 84.9 |
| Debt Metrics | ||||||||||
| Total Debt | 63.2 | 60.3 | 43.8 | 18.8 | 1.6 | 70.5 | 79.5 | 82.0 | 93.5 | 92.0 |
| Net Debt | 0.8 | 26.5 | 0.7 | (46.7) | (110.7) | 66.3 | 76.3 | 63.6 | 82.6 | 75.2 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | 83.2 | (105.5) | (46.0) | (41.5) | (8.6) | (12.8) | (24.5) | (56.5) | (43.4) | (16.5) |
| Depreciation & Amortization | 4.1 | 6.4 | 1.0 | 0.9 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Stock-Based Compensation | 12.6 | 14.9 | 6.0 | 4.3 | 2.4 | 2.5 | 4.4 | 6.5 | 4.6 | 6.6 |
| Change in Working Capital | (26.5) | (6.6) | 5.9 | (0.4) | (0.4) | 0.4 | (5.1) | (2.3) | (1.6) | 3.3 |
| Other Non-Cash Items | (78.5) | 5.8 | (0.3) | 18.0 | 0.5 | 7.2 | 3.2 | 3.7 | 6.9 | (30.2) |
| Operating Cash Flow | (1.6) | (69.7) | (33.5) | (18.7) | 10.4 | (1.9) | (23.7) | (54.2) | (33.1) | (29.8) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.8) | 0 | (0.3) | (0.1) | (0.1) | (0.0) | (0.0) | (0.0) | (0.2) | (0.6) |
| Acquisitions | 0 | 0 | (30.4) | (14.1) | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (310.0) | (41.2) | (45.8) | (22.5) | (15.4) | 0 | 0 | 0 | (27.4) | (89.8) |
| Sales/Maturities of Investments | 328.5 | 25 | 59.1 | 36.6 | 0 | 0 | 3.3 | 33.4 | 55.0 | 44.6 |
| Other Investing Activities | 0.4 | (6) | 0 | (36.6) | 0 | 0 | 0 | 33.4 | 27.6 | (1.1) |
| Investing Cash Flow | 18.1 | (22.2) | (17.4) | (36.7) | (15.5) | (0.0) | 3.2 | 33.3 | 27.4 | (46.9) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 16.3 | 25.6 | 12.8 | (38.1) | 2.9 | 5.2 | (0.2) | (0.2) | 62.2 |
| Stock Repurchased | 0 | 0 | (3.4) | (4.7) | (2.8) | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.4) | 1.3 | 6.3 | 0.3 | 104.7 | (0.0) | (0.3) | (0.1) | (0.0) | (1.0) |
| Financing Cash Flow | 12.1 | 82.1 | 28.5 | 8.4 | 113.1 | 2.7 | 4.9 | 28.0 | (0.2) | 61.2 |
| Cash Position | ||||||||||
| Net Change in Cash | 28.6 | (9.3) | (22.4) | (46.9) | 108.0 | 0.8 | (15.6) | 7.1 | (5.9) | (15.6) |
| Cash at Beginning | 33.8 | 43.0 | 65.5 | 112.3 | 4.3 | 3.6 | 19.1 | 12.0 | 17.9 | 32.3 |
| Cash at End | 62.4 | 33.8 | 43.0 | 65.5 | 112.3 | 4.3 | 3.6 | 19.1 | 12.0 | 16.8 |
| Free Cash Flow | (2.4) | (69.7) | (33.8) | (18.8) | 10.3 | (2.0) | (23.8) | (54.2) | (33.3) | (30.4) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||
| Revenue | 106.5 | 23.6 | 27.5 | 10.2 | 28.6 | 13.3 | 12.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 90.0 | 16.2 | 24.5 | 9.9 | 26.6 | 12.0 | 9.9 | (0.3) | (0.3) | (0.2) | (0.1) | 0 | 0 | 0 |
| Operating Income | (4.2) | (87.0) | (49.6) | (42.6) | 7.7 | (5.6) | (20.3) | (55.9) | (33.4) | (37.5) | (22.8) | (16.4) | (4.7) | (5.3) |
| Net Income | 83.2 | (105.5) | (46.0) | (26.8) | (8.6) | (12.8) | (24.5) | (56.5) | (43.4) | (16.5) | (54.7) | (24.5) | (5.2) | (0.1) |
| EPS (Diluted) | 1.35 | -2.28 | -1.30 | -0.78 | -2.11 | -3.21 | -13.23 | -50.39 | -47.37 | -18.10 | -118.69 | -31.79 | -10.69 | -0.47 |
| Balance Sheet | ||||||||||||||
| Cash & Equivalents | 62.4 | 33.8 | 43.0 | 65.5 | 112.3 | 4.2 | 3.2 | 18.4 | 10.9 | 16.8 | ||||
| Total Assets | 284.7 | 178.1 | 172.3 | 115.3 | 132.9 | 11.2 | 10.5 | 26.7 | 52.5 | 84.9 | ||||
| Total Debt | 63.2 | 60.3 | 43.8 | 18.8 | 1.6 | 70.5 | 79.5 | 82.0 | 93.5 | 92.0 | ||||
| Stockholders' Equity | 154.7 | 39.7 | 61.9 | 75.1 | 127.1 | (66.4) | (74.5) | (66.6) | (57.5) | (18.7) | ||||
| Cash Flow | ||||||||||||||
| Operating Cash Flow | (1.6) | (69.7) | (33.5) | (18.7) | 10.4 | (1.9) | (23.7) | (54.2) | (33.1) | (29.8) | ||||
| Capital Expenditure | (0.8) | 0 | (0.3) | (0.1) | (0.1) | (0.0) | (0.0) | (0.0) | (0.2) | (0.6) | ||||
| Free Cash Flow | (2.4) | (69.7) | (33.8) | (18.8) | 10.3 | (2.0) | (23.8) | (54.2) | (33.3) | (30.4) | ||||